Literature DB >> 6652445

Disrupting injuries of the membranous urethra--the case for early surgery and catheter splinting.

I H Al-Ali, I Husain.   

Abstract

We reviewed the outcome following primary definitive repair by catheter splinting in 16 patients presenting with total posterior urethral disruption following pelvic injury. There were two deaths in the early post-operative period due to pulmonary embolism associated with other serious injuries. Five patients were judged to have a significant stricture at the site of injury, but all proved amenable to management with endoscopic treatment or periodic dilatation. None required a urethroplasty. The two cases with stress incontinence were related to concomitant injury of the bladder neck. Impotence persisted in 2 or 5 patients followed for longer than 12 months. Complications from catheter traction were not seen using the system of light interrupted traction described. A case is made for primary management by catheter splinting of such urethral injuries.

Entities:  

Mesh:

Year:  1983        PMID: 6652445     DOI: 10.1111/j.1464-410x.1983.tb03412.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  4 in total

1.  The place of abdominal safety line in the treatment of posterior urethral injury.

Authors:  M S Murshidi
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

Review 2.  The management of the acute setting of pelvic fracture urethral injury (realignment vs. suprapubic cystostomy alone).

Authors:  Jonathan N Warner; Richard A Santucci
Journal:  Arab J Urol       Date:  2014-09-17

Review 3.  Pro: endoscopic realignment for pelvic fracture urethral injuries.

Authors:  Daniel M Stein; Richard A Santucci
Journal:  Transl Androl Urol       Date:  2015-02

Review 4.  Pelvic fracture urethral injury in males-mechanisms of injury, management options and outcomes.

Authors:  Rachel C Barratt; Jason Bernard; Anthony R Mundy; Tamsin J Greenwell
Journal:  Transl Androl Urol       Date:  2018-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.